Check patentability & draft patents in minutes with Patsnap Eureka AI!

Extracellular matrix biomaterial for resisting cell premature senility and preparation method and application thereof

A biomaterial and extracellular matrix technology, applied in the field of extracellular matrix biomaterials against premature cell aging and their preparation, can solve problems such as premature cell aging

Inactive Publication Date: 2016-08-17
THE FIRST AFFILIATED HOSPITAL OF SOOCHOW UNIV
View PDF4 Cites 2 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0007] The object of the present invention is to provide a kind of extracellular matrix biomaterial for resisting premature cell aging, and the Method and application of extracellular matrix biomaterial (ECM) against premature cell aging

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Extracellular matrix biomaterial for resisting cell premature senility and preparation method and application thereof
  • Extracellular matrix biomaterial for resisting cell premature senility and preparation method and application thereof
  • Extracellular matrix biomaterial for resisting cell premature senility and preparation method and application thereof

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0037] Example 1 Preparation of extracellular matrix biomaterial (ECM) against premature cell aging

[0038] Human UC-MSCs umbilical cord-derived mesenchymal stem cells, UC-MSCs) at 37℃, 5%CO 2 Cultivated at 175cm in the incubator 2 In the culture bottle of complete medium (the volume ratio of each component of the medium is: 89% α-MEM, 10% fetal bovine serum, 1% penicillin, 1% streptomycin), change the medium every three days . When the cell density is close to 90%, digest the cells with 0.25% trypsin-EDTA at 5000 / cm 2 Inoculate in a well plate and cultivate until reaching 90% confluency, add 100 μM ascorbic acid to continue culturing for 8 days, and change the medium once every three days. After 8 days, in order to obtain free ECM, the cultured cells were added to the decellularization mixture (prepared from pH 7.4 phosphate buffer solution, containing 0.5% Triton X-100 and 20mM ammonia water) and incubated at 37°C for 5 minutes. Then the decellularized ECM was washed 3...

Embodiment 2

[0039] Example 2 ECM to various concentrations of H 2 o 2 Effects of SA-β-Gal staining positive rate, intracellular ROS and cell cycle distribution in stem cells after treatment

[0040] Human UC-MSCs were stored at 37°C, 5% CO 2 Cultivated at 175cm in the incubator 2 In the culture bottle (the volume ratio of each component of the medium is 89% α-MEM, 10% fetal bovine serum, 1% penicillin, streptomycin), the medium is changed every three days. When the cell density is close to 90%, digest the cells with 0.25% trypsin-EDTA at 5000 / cm 2 Inoculate in well-plates of various specifications (12 wells) pretreated (the method is to incubate the TCPS plate with 0.2% gelatin at 37°C for 1 hour, then incubate with 1% glutaraldehyde and 1M ethanolamine at room temperature for 30 minutes) Plate for SA-β-Gal staining, 6-well plate for ROS content, cell cycle, RT-PCR determination, 75cm 2 Flasks for p16 INK4α protein analysis) culture until reaching 90% confluency, adding 100 μM asco...

Embodiment 3

[0051] Example 3 ECM to various concentrations of H 2 o 2 p16 in stem cells after treatment INK4α effects on gene and protein expression.

[0052] A. ECM for various concentrations of H 2 o 2 p16 in stem cells after treatment INK4α The impact of gene level changes ECM construction and cell culture methods are the same as in Example 1. The adherent cells are lysed with TRIzol reagent and then total RNA is extracted. According to the operation steps of the cDNA reverse transcription kit (Thermo Fisher Company, USA), 1 μg of total RNA is reversed. recorded as cDNA. To quantify mRNA expression, cDNA equivalent to 50 ng of RNA was used with the Universal Fluorescent Dye Supermix Kit (iTap TM UniversalSYBR Green Supermix kit) in CFX96 TM The polymerase chain reaction was performed on the real-time PCR reaction machine according to the operation steps provided by the manufacturer. We detected the senescence-associated gene p16 INK4α , GAPDH was used as an internal reference...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The present invention discloses an extracellular matrix biomaterial for resisting cell premature senility and a preparation method and application thereof. The matrix is secreted from culture of umbilical cord mesenchymal stem cells and is resistant to cell premature senility. The umbilical cord mesenchymal stem cells are cultured in a complete medium; when the cell density is close to 90%, a complete culture solution containing ascorbic acid is added, and culture is carried out for 7-10 days; then a cell removal solution is added to construct an extracellular matrix biomaterial. The umbilical cord mesenchymal stem cells are obtained from human source, swine source, murine source or rabbit source. The extracellular matrix biomaterial for resisting cell premature senility can be applied to cell culture, including cell transplantation therapy, regenerative medicine and tissue engineering, etc. Studies show that the intracellular MSCs cultured in ECM environment has ROS content significantly decreased, which confirms that ECM from UC-MSCs can alleviate the UC-MSCs premature senility induced by H2O2 and provide a new policy to address the challenges brought by cells aging.

Description

technical field [0001] The invention belongs to the technical field of tissue engineering biomaterials, and in particular relates to an anti-aging extracellular matrix biomaterial and its preparation method and application. Background technique [0002] Mesenchymal stem cells (mesenchymal stem cells, MSCs) can be obtained from a variety of adult tissues. Due to the characteristics of self-renewal, multi-lineage differentiation and immune compatibility of MSCs, they have attracted clinical attention in regenerative medicine and tissue engineering based on cell theory. extensive attention. The autologous sources of MSCs are mainly derived from bone marrow stroma, adipose tissue, synovial tissue and skin tissue. MSCs are conveniently obtained from these tissues, do not involve moral and ethical issues, and are convenient for clinical and experimental research. Recently, MSCs are derived from extraembryonic tissues, such as human umbilical cord-derived MSCs (human umbilical co...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): A61L27/36A61L27/54A61K35/28A61P39/06A61K8/98A61Q19/08
CPCA61K8/981A61K35/28A61L27/3633A61L27/54A61L2300/40A61Q19/08
Inventor 何帆周龙陈曦张文罗宗平杨惠林
Owner THE FIRST AFFILIATED HOSPITAL OF SOOCHOW UNIV
Features
  • R&D
  • Intellectual Property
  • Life Sciences
  • Materials
  • Tech Scout
Why Patsnap Eureka
  • Unparalleled Data Quality
  • Higher Quality Content
  • 60% Fewer Hallucinations
Social media
Patsnap Eureka Blog
Learn More